Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
However, the clinical spectrum of patients with COL9A1 variants can also include multiple epiphyseal dysplasia, as well as non-syndromic HL that was observed in one previously reported proband.
|
31315069 |
2019 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
PSACH and the largest proportion of autosomal dominant MED (AD-MED) results from mutations in cartilage oligomeric matrix protein (COMP); however, AD-MED is genetically heterogenous and can also result from mutations in matrilin-3 (MATN3) and type IX collagen (COL9A1, COL9A2, and COL9A3).
|
21922596 |
2012 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TSP-5 is of interest because mutations in the gene cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED/EDM1).
|
18193163 |
2008 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in cartilage oligomeric matrix protein (COMP) cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED/EDM1).
|
17200202 |
2007 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We describe a Japanese family with an autosomal dominant multiple epiphyseal dysplasia (MED EDM2) showing significant phenotypic diversity among the five affected members.
|
16440132 |
2006 |
Multiple Epiphyseal Dysplasia
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Six genes involved in MED, COMP, MATN3, COL9A1, COL9A2, COL9A3, and DTDST have been identified; however, the presence of additional disease genes has been reported, and the detection rate for mutations in known genes accounts for no more than 50% of patients with MED in Western populations.
|
16691584 |
2006 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Over 70 mutations in the cartilage oligomeric matrix protein (COMP), a large extracellular pentameric glycoprotein synthesized by chondrocytes, have been identified as causing two skeletal dysplasias: multiple epiphyseal dysplasia (MED/EDM1), and a dwarfing condition, pseudoachondroplasia (PSACH).
|
16514635 |
2006 |
Multiple Epiphyseal Dysplasia
|
0.700 |
Biomarker
|
disease |
CTD_human |
A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.
|
16909383 |
2006 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
More than 60 unique COMP mutations have been identified as causing two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED/EDM1).
|
15694129 |
2005 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the COMP gene cause two dominantly inherited skeletal dysplasias, pseudoachondroplasia (PSACH) and Multiple Epiphyseal Dysplasia (MED/EDM1).
|
15183431 |
2004 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our study provides evidence that at least another locus, distinct from COL9A1, is involved in autosomal dominant MED.
|
11528506 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Recombination was observed between COL9A1, COL9A2, COL9A3, and COMP and the MED phenotype in two of the families, and between COL9A2, COL9A3, and COMP and the phenotype in the other two families.
|
11565064 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations causing MED have now been identified in five other genes (COL9A1, COL9A2, COL9A3, DTDST, and MATN3), making MED one of the most genetically heterogeneous disorders.
|
11891674 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A genomewide screen of family with autosomal-dominant MED not linked to the EDM1-3 genes provides significant genetic evidence for a MED locus on the short arm of chromosome 2 (2p24-p23), and a search for candidate genes identified MATN3 (ref.
|
11479597 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The results show that mutations in COL9A1 can cause MED, but they also suggest that mutations in COL9A1, COL9A2, COL9A3, COMP, and DTDST are not the major causes of MED and that there exists at least one additional locus.
|
11565064 |
2001 |
Multiple Epiphyseal Dysplasia
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
STICKLER SYNDROME, TYPE IV
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population.
|
16691584 |
2006 |
STICKLER SYNDROME, TYPE IV
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.
|
11565064 |
2001 |
STICKLER SYNDROME, TYPE IV
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
STICKLER SYNDROME, TYPE IV
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
STICKLER SYNDROME, TYPE IV
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
EPIPHYSEAL DYSPLASIA, MULTIPLE, 6
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Comprehensive screening of multiple epiphyseal dysplasia mutations in Japanese population.
|
16691584 |
2006 |
EPIPHYSEAL DYSPLASIA, MULTIPLE, 6
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.
|
11565064 |
2001 |
EPIPHYSEAL DYSPLASIA, MULTIPLE, 6
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
EPIPHYSEAL DYSPLASIA, MULTIPLE, 6
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|